Joell J. Gills

4.0k citations

47 papers · 3.2k indexed · 1 hit paper · h-index 28

Oncology top 2%
- Cancer-related Molecular Pathways 6
- Cancer Immunotherapy and Biomarkers 4
Cancer Research top 5%
Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 15
- Metabolism, Diabetes, and Cancer 5
- Biochemical and Molecular Research 4
- Cell death mechanisms and regulation 4
- Protein Kinase Regulation and GTPase Signaling 4
Toxicology top 2%
Virology top 5%
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 5

Co-authors: Phillip A. Dennis Regan M. Memmott Hiroshi Kitagawa Courtney A. Granville Jaclyn LoPiccolo Shigeru Kawabata Junji Tsurutani John M. Pezzuto
Cited by: Oncology Cancer Research Molecular Biology
Journals: Journal of Biological Chemistry (1 paper)PLoS ONE (1 paper)Journal of Molecular Biology (1 paper)
Partner nations: United States Japan Canada

In The Last Decade

Joell J. Gills

46 papers receiving 3.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Joell J. Gills

Since Specialization

Citations

This map shows the geographic impact of Joell J. Gills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joell J. Gills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joell J. Gills more than expected).

Fields of papers citing papers by Joell J. Gills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joell J. Gills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joell J. Gills. The network helps show where Joell J. Gills may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Joell J. Gills, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joell J. Gills Line = papers co-authored together Joell J. Gills links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia International Journal of Oncology ·Yoon Soo Chang,Joell J. Gills,Shigeru Kawabata,Masahiro Onozawa,Giusy Della Gatta,Adolfo A. Ferrando,Peter D. Aplan,Phillip A. Dennis	2023	5
2	A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors Clinical Cancer Research ·Fyza Y. Shaikh,James R. White,Joell J. Gills,Taiki Hakozaki,Corentin Richard,Bertrand Routy,Yusuke Okuma,Mykhaylo Usyk,Abhishek Pandey,Jeffrey S. Weber,Jiyoung Ahn,Evan J. Lipson,Jarushka Naidoo,Drew M. Pardoll,Cynthia L. Sears	2021	27
3	Nelfinavir Inhibits the Growth of Small-cell Lung Cancer Cells and Patient-derived Xenograft Tumors Anticancer Research ·Shigeru Kawabata,Nick Connis,Joell J. Gills,Christine L. Hann,Phillip A. Dennis	2021	5
4	Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancerbreakdown → Cancer Research ·Kristin J. Lastwika,Willie Wilson,Qing Kay Li,Jeffrey W. Norris,Haiying Xu,Sharon R. Ghazarian,Hiroshi Kitagawa,Shigeru Kawabata,Janis M. Taube,Sheng Yao,Linda N. Liu,Joell J. Gills,Phillip A. Dennis	2015	643
5	SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines Lung Cancer ·İrem Doğan,Shigeru Kawabata,Emily Anne Smith Bergbower,Joell J. Gills,Abdullah Ekmekçi,Willie Wilson,Charles M. Rudin,Phillip A. Dennis	2014	25
6	Inhibition of Lung Tumorigenesis by Metformin Is Associated with Decreased Plasma IGF-I and Diminished Receptor Tyrosine Kinase Signaling Cancer Prevention Research ·Brendan Quinn,Matthew C. Dallos,Hiroshi Kitagawa,Ajaikumar B. Kunnumakkara,Regan M. Memmott,M. Christine Hollander,Joell J. Gills,Phillip A. Dennis	2013	68
7	Repositioning metformin for cancer prevention and treatment Trends in Endocrinology and Metabolism ·Brendan Quinn,Hiroshi Kitagawa,Regan M. Memmott,Joell J. Gills,Phillip A. Dennis	2013	232
8	Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells Cell Death and Disease ·Shigeru Kawabata,Joell J. Gills,J R Mercado-Matos,Jaclyn LoPiccolo,Wyndham H. Wilson,M. Christine Hollander,Phillip A. Dennis	2012	59
9	Lipid Molecules Induce p38α Activation via a Novel Molecular Switch Journal of Molecular Biology ·N. Tzarum,Y. Eisenberg-Domovich,Joell J. Gills,Phillip A. Dennis,Oded Livnah	2012	25
10	Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine Cell Death and Disease ·Joell J. Gills,C Zhang,Mones Abu‐Asab,S. Sianna Castillo,Caleb Marceau,Jaclyn LoPiccolo,Alan P. Kozikowski,Maria Tsokos,Tzipora Goldkorn,Phillip A. Dennis	2012	18
11	Expression Signatures of the Lipid-Based Akt Inhibitors Phosphatidylinositol Ether Lipid Analogues in NSCLC Cells Molecular Cancer Therapeutics ·Chunyu Zhang,Abdel Elkahloun,Hongling Liao,Shannon M. Delaney,Barbara Saber,Betsy Morrow,George C. Prendergast,M. Christine Hollander,Joell J. Gills,Phillip A. Dennis	2011	10
12	Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo Clinical Cancer Research ·Joell J. Gills,Jaclyn LoPiccolo,Junji Tsurutani,Robert H. Shoemaker,Carolyn J.M. Best,Mones Abu‐Asab,Jennifer Borojerdi,Noel A. Warfel,Erin R. Gardner,Matthew Danish,M. Christine Hollander,Shigeru Kawabata,Maria Tsokos,William D. Figg,Patricia S. Steeg,Phillip A. Dennis	2007	264
13	Targeting Akt in cancer therapy Anti-Cancer Drugs ·Jaclyn LoPiccolo,Courtney A. Granville,Joell J. Gills,Phillip A. Dennis	2007	109
14	A Comparative Evaluation of the Anticancer Properties of European and American Elderberry Fruits Journal of Medicinal Food ·Julie M. Thole,Tristan F. Burns Kraft,Lilly Ann Sueiro,Young-Hwa Kang,Joell J. Gills,Muriel Cuendet,John M. Pezzuto,David S. Seigler,Mary Ann Lila	2006	51
15	Effect of Deguelin on UVB-Induced Skin Carcinogenesis Journal of Chemotherapy ·Joell J. Gills,Jerome W. Kosmeder,R C Moon,Daniel D. Lantvit,John M. Pezzuto	2005	9
16	Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion Cancer Letters ·Joell J. Gills,Elizabeth H. Jeffery,Nathan V. Matusheski,Richard C. Moon,Daniel D. Lantvit,John M. Pezzuto	2005	96
17	The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt Expert Opinion on Investigational Drugs ·Joell J. Gills,Phillip A. Dennis	2004	37
18	Brusatol-induced HL-60 cell differentiation involves NF-κB activation Cancer Letters ·Muriel Cuendet,Joell J. Gills,John M. Pezzuto	2004	34
19	Sesquiterpenoids fromTithonia diversifoliawith Potential Cancer Chemopreventive Activity Journal of Natural Products ·Jian-Qiao Gu,Joell J. Gills,Eun‐Jung Park,Eugenia Mata‐Greenwood,Michael Hawthorne,Franklin S. Axelrod,Pedro I. Chavez,Harry H. S. Fong,Rajendra G. Mehta,John M. Pezzuto,A. Douglas Kinghorn	2002	94
20	Activity-guided isolation of constituents of Cerbera manghas with antiproliferative and antiestrogenic activities Bioorganic & Medicinal Chemistry Letters ·Leng Chee Chang,Joell J. Gills,Krishna Bhat,Lumonadio Luyengi,Norman R. Farnsworth,John M. Pezzuto,A. Douglas Kinghorn	2000	34

About Joell J. Gills

Joell J. Gills is a scholar working on Virology, Oncology and Toxicology, having authored 47 papers that have together received 3.2k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer-related Molecular Pathways (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Lung Cancer Treatments and Mutations (5 papers), Biochemical and Molecular Research (4 papers), Cell death mechanisms and regulation (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (452 citations) and Molecular Biology (2.0k citations). Joell J. Gills has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Phillip A. Dennis, Regan M. Memmott, Hiroshi Kitagawa, Courtney A. Granville, Jaclyn LoPiccolo, Shigeru Kawabata, Junji Tsurutani, John M. Pezzuto, Brendan Quinn and Willie Wilson. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact